consent to our use of cookies . to learn more about the types of cookies we use please view our cookie policy . continue using the site product query or adverse event careers contact us international about history executive committee the board grants diseases of addiction a worldwide crisis the patient journey r & d publications white papers sponsored supplements products investors media investor information annual reports latest news rns filings rns filings inside information sec filings corporate alert service webcasts audiocasts presentations prospectus upcoming events results and reporting buprenorphine market modeling methodology share price information share price center share price table historic share price share price calculator demerger base cost corporate governance leadership statement of compliance the board board committees the executive team executive committees corporate compliance indivior global conduct policies good conduct shareholder information managing your shareholding dividends annual general meeting american depositary receipts contact us addiction is a treatable chronic condition not a moral failing . science reveals the truth . addiction does not discriminate . it impacts all walks of life . over 145 million people worldwide are dependent on opioids or alcohol . this must change . focus on you . one day addiction will no longer be viewed through the social lens of scorn and shame . one day addiction will no longer be a global humanitarian crisis . we at indivior envision a day in which all patients around the world will have unrestricted access to quality treatments and services for the chronic relapsing conditions and co morbidities of addiction . until that day comes we will continue to pioneer life transforming treatments . and with the help of healthcare professionals the public health community policy makers payers and people like you we will shift public perceptions of these often underserved patient populations humanize their suffering and medicalize addiction as a chronic relapsing condition that should be treated similarly to other chronic diseases . together we will break down barriers to treatment for millions of people across the globe who need it most . this is our vision . we are indivior and we will always focus on you . vigilance report an adverse event or request medical information about any of our products . about us a patient focused business with a public health mindset . investors get involved with our success . careers a pioneering culture driven by guiding principles . media learn more about our products culture and company . upcoming events november 2 2016 indivior q3 results see more latest news october 3 2016 pdf version indivior plc the company directorate change ... september 27 2016 pdf version statement regarding civil complaint filed by state attorneys general ... september 23 2016 pdf version indivior notified of civil complaint filed by state attorneys general ... september 20 2016 pdf version indivior grants 1.2 m to the moyer foundation ... see more about diseases of addiction products r & d investors media product query or adverse event careers contact terms of use privacy policy international employee login 2016 indivior plc this site is intended for us audiences . indivior is a registered trademark of indivior uk limited . you are now leaving indivior.com to visit suboxone.com a us product site intended for us residents and healthcare professionals . continue return you are now leaving indivior.com . continue return